about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
0.75
-0.03
(-3.85%)
148.0K
XNAS Volume
XNAS 17 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Scynexis Inc is on 25 Jun 2025 for the purpose of SCYNEXIS Inc Annual General Meeting for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..